Development of Rabies Virus-Like particles for Vaccine applications: Production, Characterization, and protection Studies

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Development of rabies virus-like particles suggests enhanced immune response, indicating potential for improved vaccine efficacy.

Vaccination with rabies virus-like particles provided complete protection against lethal rabies virus challenge.
Production using recombinant baculovirus yielded high quantities of virus-like particles, facilitating scalability.
Characterization confirmed that virus-like particles mimic the native rabies virus in form and function.
Studies demonstrated strong immune responses with high levels of neutralizing antibodies raised by the rabies virus-like particles.

Haider et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark